RSVAX Fees and Costs — Victory RS Value Fund, Class A
Data updated: 2026-08-26
The net expense ratio is 1.30%: a 0.85% management fee, a 0.25% 12b-1 fee plus 0.23% other expenses, less a 0.03% fee waiver. This share class carries a maximum front-end sales load of 5.75%. In fiscal 2025 the fund paid $165K in broker commissions, 0.0633% of average net assets, and portfolio turnover was 50%.
RSVAX Fees and Expenses
Annual operating expenses and sales charges of RSVAX. Prospectus, as of December 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.85% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.23% |
| Gross expense ratio | 1.33% |
| Fee waiver | −0.03% |
| Net expense ratio | 1.30% |
| Sales charges | |
|---|---|
| Max front load | 5.75% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | Yes |
RSVAX Costs Over Time
On $10,000 invested in RSVAX, assuming 5% a year before costs, total costs come to $1,532 over 5 years, cutting the return by 2.65% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $575 | $575 | $575 |
| Fund expenses (net expense ratio 1.30%) | $129 | $400 | $691 |
| Trading costs (broker commissions) | $6 | $19 | $34 |
| Lost growth on money paid in costs | $29 | $111 | $232 |
| Total costs | $739 | $1,106 | $1,532 |
| Value after costs | $9,761 | $10,470 | $11,231 |
| Impact on return, per year | 7.39% | 3.46% | 2.65% |
RSVAX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0633%
- Total broker commissions: $165K
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 50%
- Securities on loan, average value: $1.1M
- Net income from securities lending: $856 (0.000% of average net assets)
RSVAX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Robert W. Baird & Co. Incorporated | $17K | 17.86% |
| Barclays Capital Inc. | $15K | 15.67% |
| RBC Capital Markets, LLC | $13K | 13.74% |
| Jefferies LLC | $12K | 12.40% |
| Stifel, Nicolaus & Company, Incorporated | $8K | 8.31% |
| KeyBanc Capital Markets Inc. | $6K | 6.72% |
| Goldman Sachs & Co. LLC | $6K | 6.71% |
| J.P. Morgan Securities LLC | $6K | 6.48% |
| Mesirow Financial, Inc. | $6K | 6.11% |
| Evercore Group L.L.C. | $6K | 6.02% |
Victory RS Value Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| RSVYX | Class Y | 1.06% | none |
| RSVAX | Class A | 1.30% | 5.75% |
| RVACX | Class C | 2.07% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.